囊性纤维化治疗景观:进展,挑战和未来方向
Ceren Ayça Yıldız1, Yasemin Gökdemir1, Ela Erdem Eralp1
1Division of Pediatric Pulmonology, Marmara University School of Medicine, İstanbul, Türkiye.
Turkish archives of pediatrics
|March 17, 2025
概括
囊性纤维化 (CF) 是一种由CFTR基因变异引起的遗传疾病. 虽然CFTR调节器提供了改善的结果,但许多患者,特别是那些患有罕见突变的患者,仍然缺乏有效的治疗方法.
科学领域:
- 遗传学和分子生物学
- 肺部病理学 肺部病理学
- 胃肠病学 胃肠病学
背景情况:
- 囊性纤维化 (Cystic fibrosis,CF) 是一种影响呼吸和胃肠道系统的单一性自体逆向性疾病.
- 它源于CFTR基因的变异,导致功能障碍的化物通道和厚的粘液.
- 这导致受影响个体的多系统并发症.
研究的目的:
- 提供囊性纤维化病理生理学和遗传学的全面概述.
- 探索CF当前和新兴的治疗策略.
- 讨论管理CF治疗的持续挑战.
主要方法:
- 关于CF病理生理学的文献综述.
- 对CF遗传基础的分析.
- 审查当前和新兴的CFTR调节器疗法.
- 讨论治疗挑战和未来方向.
主要成果:
- CFTR基因变异是CF的根本原因.
- 虽然CFTR调节剂改善了许多患者的治疗结果,但它们是基因型特异性的.
- 很大一部分CF患者,特别是那些患有罕见突变的人,缺乏有效的治疗选择.
结论:
- CF病理生理学涉及CFTR基因功能障碍导致多系统性疾病.
- 虽然CFTR调节器代表了突破,但所有基因型的公平获取和治疗仍然是关键挑战.
- 需要进一步的研究来解决罕见的CF突变患者的需求,并开发出普遍有效的治疗方法.
相关概念视频
Cystic Fibrosis: Management
136
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
136
Cystic Fibrosis: Pathogenesis
174
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
174
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Pancreatitis II: Collaborative Care
54
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
54


